NICE recommends lenalidomide for treating blood disorders

NICE has issued final draft guidance recommending lenalidomide, an immunomodulatory drug also known as Revlimid, as an option for treating myelodysplastic syndromes (MDS).
Source: Nursing Times Breaking News - Category: Nursing Source Type: news